ESC 365 - Single versus dual antiplatelet therapy following transcatheter left atrial appendage closure

EHRA Premium Access

Single versus dual antiplatelet therapy following transcatheter left atrial appendage closure

Session: Moderated ePosters - How to optimise stroke prevention in atrial fibrillation

Topic: Left Atrial Appendage Closure

Speaker: Doctor A. Sabbag (Ramat Gan, IL)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Doctor Avi Sabbag

Chaim Sheba Medical Center, Ramat Gan (Israel)

5 presentations

1 follower

3 more presentations in this session

Impact of P-glycoprotein and/or CYP3A4-interacting drugs on the risk-benefit profile of NOACs in patients with atrial fibrillation: a meta-analysis

Speaker: Mr M. Grymonprez (Gent, BE)

One-year results from the FLXibility post-approval study: final real-world clinical outcomes with a next-generation left atrial appendage closure device

Speaker: Professor T. Betts (Oxford, GB)

Prevalence and outcomes of hypoattenuation defects and appendage patency on computed tomography after left atrial appendage closure

Speaker: Professor H. Cochet (Bordeaux, FR)

Access the full session

Moderated ePosters - How to optimise stroke prevention in atrial fibrillation

Speakers: Doctor A. Sabbag, Mr M. Grymonprez, Professor T. Betts, Professor H. Cochet

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources